Literature DB >> 11945020

Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel.

Ting C Zhao1, Rakesh C Kukreja.   

Abstract

Activation of adenosine A(3) receptor (A(3)AR) protects against ischemia/reperfusion injury in the heart. However, the downstream signaling mechanisms leading to its delayed anti-ischemic effects remain unclear. We hypothesized that A(3)AR stimulation protects the heart via activation of nuclear transcription factor kappa B (NF-kappa B) and synthesis of inducible nitric oxide synthase (iNOS). Mice were treated with selective A(3)AR agonist, N(6)-(3-iodobenzyl) adenosine-5;-N-methyluronamide (IB-MECA). Twenty-four h later, hearts were perfused in Langendorff mode and subjected to 30 min of global ischemia and 30 min of reperfusion. IB-MECA caused post-ischemic reduction in necrosis and improvement in myocardial performance which was abolished by A(3)AR antagonist, MRS1191. Electrophoretic mobility shift assay demonstrated increased NF-kappa B binding in nuclear extracts following A(3)AR stimulation, which was diminished by MRS1191 and NF-kappa B inhibitor, pyrrolidinediethyldithiocarbamate (PDTC). The cardioprotection was abrogated by PDTC and targeted ablation of p50 subunit of NF-kappa B in mice. The inhibition of iNOS with S-methylisothiourea and targeted disruption of the iNOS gene also abolished the protective effect of A(3)AR stimulation. Expression of iNOS mRNA and NO production were enhanced after 6 and 24 h respectively of IB-MECA treatment. MRS1191 and PDTC blocked IB-MECA induced NO production after A(3)AR stimulation. MitoK(ATP) channel blocker, 5-hydroxydecanoate abolished the protective effect of A(3)AR. For the first time, we have provided direct evidence of an essential role of NF- kappa B activation and iNOS in A(3)AR-induced late preconditioning. Selective activation of A(3)AR with IB-MECA can be used to trigger long-lasting ischemic protection in the heart. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945020     DOI: 10.1006/jmcc.2001.1510

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

1.  gp-91 mediates histone deacetylase inhibition-induced cardioprotection.

Authors:  Ting C Zhao; Ling X Zhang; Guangmao Cheng; Jun T Liu
Journal:  Biochim Biophys Acta       Date:  2010-04-28

Review 2.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

3.  Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis.

Authors:  Ling Zhang; Xin Qin; Yu Zhao; Loren Fast; Shougang Zhuang; Paul Liu; Guangmao Cheng; Ting C Zhao
Journal:  J Pharmacol Exp Ther       Date:  2012-01-23       Impact factor: 4.030

4.  Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.

Authors:  L X Zhang; Y Zhao; G Cheng; T L Guo; Y E Chin; P Y Liu; T C Zhao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

5.  Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-κB and upregulation of autophagy.

Authors:  Shigang Qiao; Hong Xie; Chen Wang; Xuemei Wu; Hong Liu; Chunfeng Liu
Journal:  J Anesth       Date:  2012-11-10       Impact factor: 2.078

Review 6.  Role of microRNAs in cardiac preconditioning.

Authors:  Fadi N Salloum; Chang Yin; Rakesh C Kukreja
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

Review 7.  PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer.

Authors:  Anindita Das; David Durrant; Fadi N Salloum; Lei Xi; Rakesh C Kukreja
Journal:  Pharmacol Ther       Date:  2014-10-31       Impact factor: 12.310

8.  The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart.

Authors:  Jana S Burchfield; Jian-Wen Dong; Yasushi Sakata; Feng Gao; Huei-Ping Tzeng; Veli K Topkara; Mark L Entman; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2009-10-30       Impact factor: 8.790

9.  IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.

Authors:  Buddhadeb Dawn; Yu-Ting Xuan; Yiru Guo; Arash Rezazadeh; Adam B Stein; Greg Hunt; Wen-Jian Wu; Wei Tan; Roberto Bolli
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

10.  Acidic preconditioning protects endothelial cells against apoptosis through p38- and Akt-dependent Bcl-xL overexpression.

Authors:  Jan-Paul Flacke; Sanjeev Kumar; Sawa Kostin; H Peter Reusch; Yury Ladilov
Journal:  Apoptosis       Date:  2009-01       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.